Original Article

You have full text access to this OnlineOpen article

Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures†

  1. Per Aspenberg1,*,
  2. Harry K Genant2,3,
  3. Torsten Johansson1,
  4. Antonio J Nino4,
  5. Kyoungah See4,
  6. Kelly Krohn4,
  7. Pedro A García-Hernández5,
  8. Christopher P Recknor6,
  9. Thomas A Einhorn7,
  10. Gail P Dalsky4,
  11. Bruce H Mitlak4,
  12. Anke Fierlinger3,
  13. Mark C Lakshmanan4

Article first published online: 14 DEC 2009

DOI: 10.1359/jbmr.090731

Issue

Journal of Bone and Mineral Research

Journal of Bone and Mineral Research

Volume 25, Issue 2, pages 404–414, February 2010

Additional Information

How to Cite

Aspenberg, P., Genant, H. K., Johansson, T., Nino, A. J., See, K., Krohn, K., García-Hernández, P. A., Recknor, C. P., Einhorn, T. A., Dalsky, G. P., Mitlak, B. H., Fierlinger, A. and Lakshmanan, M. C. (2010), Teriparatide for acceleration of fracture repair in humans: A prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res, 25: 404–414. doi: 10.1359/jbmr.090731

Author Information

  1. 1

    Orthopaedics, Linköping University, Linköping, Sweden

  2. 2

    University of California–San Francisco, San Francisco, CA, USA

  3. 3

    Synarc, Inc., San Francisco, CA, USA

  4. 4

    Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

  5. 5

    Depto de Endocrinología, Centro de Osteoporosis, Hospital Universitario de Nuevo León, Monterrey, Mexico

  6. 6

    United Osteoporosis Centers, Gainesville, GA, USA

  7. 7

    Boston University Medical Center, Boston, MA, USA

*Section for Orthopaedics, IKE Faculty of Health Sciences, Linköping University, Linköping, Sweden 581 85.

  1. †

    Data included in this manuscript were presented in part at the 35th ECTS Congress, Barcelona, Spain, 24–28 May 2008. Abstract publication: Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, Garcia P, Recknor CP, Einhorn TA, Dalsky GP, Lakshmanan M. Effects of teriparatide on distal radial fracture healing in postmenopausal women: a randomized double-blinded study [abstract no. Su-P417]. Calcif Tissue Int. 2008;82:S218.

Publication History

  1. Issue published online: 19 FEB 2010
  2. Article first published online: 14 DEC 2009
  3. Manuscript Accepted: 8 JUL 2009
  4. Manuscript Revised: 18 MAY 2009
  5. Manuscript Received: 2 DEC 2008

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (173K)

References

  • 1
    Johnell O, Kanis J. Epidemiology of osteoporotic fractures. Osteoporos Int. 2005; 16: S3–S7.
  • 2
    Johnell O. The socioeconomic burden of fractures: today and in the 21st century. Am J Med. 1997; 103: 20S–25S.
  • 3
    Boonen S, Singer AJ. Osteoporosis management: impact of fracture type on cost and quality of life in patients at risk for fracture I. Curr Med Res Opin. 2008; 24: 1781–1788.
  • 4
    D'Amelio P, Di Stefano M, Isaia G. Health-related quality of life in severe osteoporosis. Aging Clin Exp Res. 2007; 19: 28–30.
  • 5
    Axelrad TW, Kakar S, Einhorn TA. New technologies for the enhancement of skeletal repair. Injury. 2007; 38: S49–S62.
  • 6
    Bishop GB, Einhorn TA. Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery. Int Orthop. 2007; 31: 721–727.
  • 7
    Kristiansen TK, Ryaby JP, McCabe J, Frey JJ, Roe LR. Accelerated healing of distal radial fractures with the use of specific, low-intensity ultrasound: a multicenter, prospective, randomized, double-blind, placebo-controlled study. J Bone Joint Surg Am. 1997; 79: 961–973.
  • 8
    Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002; 84-A: 2123–2134.
  • 9
    Diefenderfer DL, Osyczka AM, Garino JP, Leboy PS. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells. J Bone Joint Surg Am. 2003; 85: 19–28.
  • 10
    Barnes GL, Kakar S, Vora S, Morgan EF, Gerstenfeld LC, Einhorn TA. Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. J Bone Joint Surg Am. 2008; 90: S120–S127.
  • 11
    Chalidis B, Tzioupis C, Tsiridis E, Giannoudis PV. Enhancement of fracture healing with parathyroid hormone: preclinical studies and potential clinical applications. Expert Opin Investig Drugs. 2007; 16: 441–449.
  • 12
    Skripitz R, Aspenberg P. Parathyroid hormone: a drug for orthopedic surgery? Acta Orthop Scand. 2004; 75: 654–662.
  • 13
    Andreassen TT, Ejersted C, Oxlund H. Intermittent parathyroid hormone(1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res. 1999; 14: 960–968.
  • 14
    Holzer G, Majeska RJ, Lundy MW, Hartke JR, Einhorn TA. Parathyroid hormone enhances fracture healing: a preliminary report. Clin Orthop Relat Res. 1999; 366: 258–263.
  • 15
    Kim HW, Jahng JS. Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Iowa Orthop J. 1999; 19: 71–77.
  • 16
    Nakajima A, Shimoji N, Shiomi K, et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res. 2002; 17: 2038–2047.
  • 17
    Nakazawa T, Nakajima A, Shiomi K, Moriya H, Einhorn TA, Yamazaki M. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone(1-34) on chondrogenesis in a model of experimental fracture healing. Bone. 2005; 37: 711–719.
  • 18
    Skripitz R, Andreassen TT, Aspenberg P. Strong effect of PTH(1-34) on regenerating bone: a time sequence study in rats. Acta Orthop Scand. 2000; 71: 619–624.
  • 19
    Skripitz R, Andreassen TT, Aspenberg P. Parathyroid hormone(1-34) increases the density of rat cancellous bone in a bone chamber: a dose-response study. J Bone Joint Surg Br. 2000; 82: 138–141.
  • 20
    Andreassen TT, Fledelius C, Ejersted C, Oxlund H. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone. Acta Orthop Scand. 2001; 72: 304–307.
  • 21
    Goldhahn J, Scheele WH, Mitlak BH, et al. Clinical evaluation of medicinal products for acceleration of fracture healing in patients with osteoporosis. Bone. 2008; 43: 343–347.
  • 22
    Grigoryan M, Lynch JA, Fierlinger AL, et al. Quantitative and qualitative assessment of closed fracture healing using computed tomography and conventional radiography. Acad Radiol. 2003; 10: 1267–1273.
  • 23
    Lynch JA, Grigoryan M, Fierlinger A, et al. Measurement of changes in trabecular bone at fracture sites using X-ray CT and automated image registration and processing. J Orthop Res. 2004; 22: 362–367.
  • 24
    MacDermid JC, Turgeon T, Richards RS, Beadle M, Roth JH. Patient rating of wrist pain and disability: a reliable and valid measurement tool. J Orthop Trauma. 1998; 12: 577–586.
  • 25
    Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg [Am]. 1984; 9: 222–226.
  • 26
    Lee ET. Statistical Methods for Survival Data Analysis, 2nd ed. New York: Wiley; 1992.
  • 27
    Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Monographs on Statistics and Applied Probability. New York: Chapman & Hall; 1993.
  • 28
    Dmitrienko A, Tamhane AC. Gatekeeping procedures with clinical trial applications. Pharm Stat. 2007; 6: 171–180.
  • 29
    Zanchetta JR, Bogado CE, Ferretti JL, et al. Effects of teriparatide [recombinant human parathyroid hormone(1-34)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res. 2003; 18: 539–543.
  • 30
    Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone(1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001; 344: 1434–1441.
  • 31
    Chen P, Satterwhite JH, Licata AA, et al. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis. J Bone Miner Res. 2005; 20: 962–970.
  • 32
    Seebach C, Skripitz R, Andreassen TT, Aspenberg P. Intermittent parathyroid hormone(1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res. 2004; 22: 472–478.
  • 33
    Gardner MJ, van der Meulen MC, Carson J, et al. Role of parathyroid hormone in the mechanosensitivity of fracture healing. J Orthop Res. 2007; 25: 1474–1480.
  • 34
    Cook SD, Ryaby JP, McCabe J, Frey JJ, Heckman JD, Kristiansen TK. Acceleration of tibia and distal radius fracture healing in patients who smoke. Clin Orthop Relat Res, 1997; 337: 198–207.
  • 35
    Goldhahn J, Mitlak B, Aspenberg P, et al. Critical issues in translational and clinical research for the study of new technologies to enhance bone repair. J Bone Joint Surg Am. 2008; 90: 43–47.
View Full Article (HTML) Get PDF (173K)